Exelan, lenalidomide 10MG cap, oral

Ended Awarded Last action

Contract number
15B50526F00000159
Awardee
Awarding agency
Obligated
$2,261

Award facts

Contract value 100% obligated
$2,261.15 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Boca Raton, FL 33432, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 -$4,270
Original award $6,531

About this award

This delivery order awards $6.53 million to Exelan Pharmaceuticals Inc. for the supply of Lenalidomide 10mg capsules to Federal Medical Center Carswell, a civilian facility within the federal prison system. The contract represents a firm-fixed-price delivery order issued under a larger Indefinite Delivery Contract vehicle and calls for 14 doses at $466.51 per unit, with an ultimate completion date of April 30, 2026. The award was made without a set-aside designation, allowing Exelan to compete on an unrestricted, fully open basis. Exelan Pharmaceuticals, headquartered in Boca Raton, Florida, will perform the work at its primary facility in Florida, leveraging its established position as a critical supplier of generic and branded pharmaceutical products to federal healthcare systems.

Exelan Pharmaceuticals maintains an extensive portfolio of Indefinite Delivery Contracts with the Department of Veterans Affairs National Acquisition Center and Defense Logistics Agency, positioning the company as a long-term strategic supplier for federal pharmaceutical procurement. The company specializes in bulk drug repackaging and consolidation services that transform pharmaceutical products into patient-ready prescriptions, serving the Veterans Health Administration, Department of Defense, Bureau of Prisons, and Indian Health Service. This delivery order for Lenalidomide supports oncology treatment protocols and aligns with Exelan's primary recent work involving the supply of this critical medication across multiple federal healthcare networks. The contract falls under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), which provides the framework for pre-competed pharmaceutical procurement across federal agencies.

Quick answers

Who was awarded contract 15B50526F00000159?

15B50526F00000159 was awarded to Exelan Pharmaceuticals Inc. by Federal Medical Center Carswell (Correctional Facilities) on April 1, 2026.

How much is contract 15B50526F00000159 worth?

The government has obligated $2,261 on 15B50526F00000159.

Is contract 15B50526F00000159 an order under another contract?

Yes. 15B50526F00000159 is a delivery order under 36F79720D0227, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 15B50526F00000159 competed?

The extent of competition for 15B50526F00000159 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award